Elanco Animal Health (ELAN) Short term Debt (2018 - 2026)

Elanco Animal Health has disclosed Short term Debt across 9 years of filings, most recently posting $73.0 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $73.0 million, up 65.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $73.0 million (up 65.91% YoY), and the FY2025 annual result was $74.0 million, up 68.18% from the prior year.
• Short term Debt came in at $73.0 million for Q1 2026 at Elanco Animal Health, down from $74.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $394.0 million in Q3 2022 to a low of $38.0 million in Q4 2023.
• The 5-year median for Short term Debt is $61.0 million (2022), against an average of $120.5 million.
• Across the five-year window, Short term Debt jumped 545.9% in 2022 and plunged 90.21% in 2023, its largest moves.
• Elanco Animal Health's Short term Debt stood at $388.0 million in 2022, then slumped by 90.21% to $38.0 million in 2023, then increased by 15.79% to $44.0 million in 2024, then jumped by 68.18% to $74.0 million in 2025, then dropped by 1.35% to $73.0 million in 2026.
• The last three Short term Debt figures came in at $73.0 million (Q1 2026), $74.0 million (Q4 2025), and $62.0 million (Q3 2025), per Business Quant data.